Sort
15,842 grants matching “pancreatic cancer”
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer
$303,501Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Minimally invasive pancreatic cancer treatment combining nanosecond electric pulses and immune system stimulants
$303,475Richard Lee Nuccitelli · Pulse Biosciences, Inc. · R43 · FY2025 · CA
Gli Activity in the Pancreas: Inflammation, Tissue Repair and Cancer
$303,470Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
A data-driven bioinformatics platform for the design and analysis of multiplexed antibody-based cytometry experiments in cancer research
$303,418Pablo Gonzalez Camara · University Of Pennsylvania · U01 · FY2024 · CA
The Role of p16INK4a in Mammalian Aging
$303,400Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AG
Aurora Kinase as a Therapeutic Target in Cancer
$303,379University Of Arizona · R01 · FY2004 · CA
Aurora Kinase as a Therapeutic Target in Cancer
$303,379University Of Arizona · R01 · FY2003 · CA
Aurora Kinase as a Therapeutic Target in Cancer
$303,379University Of Arizona · R01 · FY2002 · CA
Selective Sensitization of Pancreatic Cancer to Therapy by Chk1 and PARP1 Inhibit
$303,194Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2012 · CA
Mechanistic Studies on New Platinum Clinical Agents
$303,155Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2012 · CA
Mechanistic Studies on New Platinum Clinical Agents
$303,155Nicholas P Farrell · Virginia Commonwealth University · R01 · FY2011 · CA
Legumain to the rescue: A new ADC linker strategy to address the limitations of cathepsin cleavage
$303,056Lawrence Tumey · State University Of Ny,Binghamton · R01 · FY2022 · GM
Legumain to the rescue: A new ADC linker strategy to address the limitations of cathepsin cleavage
$303,056Lawrence Tumey · State University Of Ny,Binghamton · R01 · FY2025 · GM
Legumain to the rescue: A new ADC linker strategy to address the limitations of cathepsin cleavage
$303,056Lawrence Tumey · State University Of Ny,Binghamton · R01 · FY2024 · GM
Legumain to the rescue: A new ADC linker strategy to address the limitations of cathepsin cleavage
$303,056Lawrence Tumey · State University Of Ny,Binghamton · R01 · FY2023 · GM
Basic Science Research in Digestive Diseases
$303,046Mark Donowitz · Johns Hopkins University · T32 · FY2018 · DK
Role of Mineralocorticoids in Hypertension
$303,000Celso Enrique Gomez-Sanchez · University Of Mississippi Med Ctr · R01 · FY2009 · HL
PROJECT 4: Targeting Methionine Adenosyltransferases in Liver Metastasis
$302,952Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · P01 · FY2024 · CA
"Smart" Nanoparticles for Cancer Therapy and Imaging
$302,940Joseph M Desimone · Univ Of North Carolina Chapel Hill · U54 · FY2007 · CA
PDG Links Stem Cell Niche to Pancreatic Epithelial Renewal, Repair and Cancer
$302,919Sarah P Thayer · University Of Nebraska Medical Center · R01 · FY2014 · CA
RO1: A novel and targeted approach to inhibit invasion and angiogenesis
$302,919Fazlul H. Sarkar · Wayne State University · R01 · FY2012 · CA
RO1: A novel and targeted approach to inhibit invasion and angiogenesis
$302,919Fazlul H. Sarkar · Wayne State University · R01 · FY2011 · CA
Neurogeneic Amplification of Pancreatitis Pain
$302,864Karin N Westlund-High · University Of Kentucky · R01 · FY2006 · NS
Kras-Induced Cellular Plasticity in Pancreatic Cancer
$302,844Stephen F Konieczny · Purdue University · R01 · FY2014 · CA
NFAT Transcription Factors as Therapeutic Targets in Pancreatic Cancer
$302,818Daniel D Billadeau · Mayo Clinic Rochester · P50 · FY2018 · CA